← All companies

ISCO

International Stem Cell Corporation

ISCO OTC Pharmaceutical Preparations EDGAR ↗

$0.25

-0.02 -7.41%

Key statistics

from XBRL data in SEC filings

Market cap

$2.00M

Revenue (TTM)

$9.29M

Net income (TTM)

-$382K

EPS (TTM)

$-0.05

P/E ratio

—

Dividend yield

—

Free cash flow

-$35.0K

Cash

$933K

Total assets

$5.13M

Gross margin

—

52-week range

$0.12 – $0.32

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement Jul 16, 2026 8-K Shareholder vote results Jun 12, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Shareholder vote results Nov 18, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Entered a material agreement; Took on a direct financial obligation Sep 16, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 10-K Fiscal year ended 2024-12-31 Mar 28, 2025 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Entered a material agreement; Took on a direct financial obligation Sep 17, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 10-K Fiscal year ended 2023-12-31 Mar 28, 2024 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Entered a material agreement; Took on a direct financial obligation Sep 18, 2023 10-Q Quarter ended 2023-06-30 Aug 11, 2023 8-K Shareholder vote results Jun 21, 2023 10-Q Quarter ended 2023-03-31 May 12, 2023 10-K Fiscal year ended 2022-12-31 Mar 30, 2023 8-K Entered a material agreement; Took on a direct financial obligation Mar 16, 2023 10-Q Quarter ended 2022-09-30 Nov 14, 2022 8-K Entered a material agreement; Took on a direct financial obligation Sep 16, 2022 10-Q Quarter ended 2022-06-30 Aug 12, 2022 8-K Shareholder vote results Jun 14, 2022 10-Q Quarter ended 2022-03-31 May 13, 2022 8-K Director or officer change Apr 29, 2022 10-K Fiscal year ended 2021-12-31 Mar 29, 2022 8-K Entered a material agreement; Took on a direct financial obligation Mar 3, 2022 8-K Director or officer change Feb 2, 2022 8-K Entered a material agreement; Took on a direct financial obligation Jan 14, 2022 8-K Terminated a material agreement Dec 28, 2021 10-Q Quarter ended 2021-09-30 Nov 12, 2021 8-K Entered a material agreement Nov 1, 2021 10-Q Quarter ended 2021-06-30 Aug 13, 2021 8-K Amended charter or bylaws Jun 30, 2021 8-K Shareholder vote results Jun 14, 2021 10-Q Quarter ended 2021-03-31 May 14, 2021 10-K Fiscal year ended 2020-12-31 Mar 30, 2021